Nu-Med Plus, Inc. engages in the design, development, and marketing of technologies utilizing nitric oxide in the medical device field. The company is headquartered in Salt Lake City, Utah and currently employs 2 full-time employees. The company went IPO on 2013-08-02. The company focuses on the creation of a nitric oxide (NO) generating formulation, a hospital bedside NO delivery system, a clinical unit for use in medical clinics and rehabilitation centers and a mobile rechargeable device to deliver nitric oxide gas to offer solutions to hospitals, health systems and the medical community throughout the world. Hospital NO Unit delivers a continuous intra-breath concentration of therapeutic NO to patients who are on a ventilator in a hospital setting. The Clinical Delivery System is a simplified version of the hospital unit. Portable Delivery System delivers NO to the patient at prescribed intervals for 24 hours per day at controlled doses by means of a nasal cannula or a face mask. Reagent Delivery offers a range of concentrations and flow rates of NO.
Follow-Up Questions
Nu-Med Plus Inc의 CEO는 누구입니까?
Mr. William Hayde은 2022부터 회사에 합류한 Nu-Med Plus Inc의 Executive Chairman of the Board입니다.
NUMD 주식의 가격 성능은 어떻습니까?
NUMD의 현재 가격은 $0.0312이며, 전 거래일에 decreased 0% 하였습니다.
